Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline for cognitive, social, and speech outcomes in autistic children
IRCT20241029063537N2Phase 4Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Autism Spectrum Disorder (ASD) comparing Citicoline + usual treatment with Placebo + usual treatment (2 arms). Primary endpoint: Cognitive status. Started Jul 2025; status: completed.
02
Drugs
citicoline
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT20241029063537N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241029063537N2.